Resecting large numbers of hepatic colorectal metastases

ANZ Journal of Surgery - Tập 72 Số 1 - Trang 5-10 - 2002
Paul Moroz1, Paul Salama1, Bruce N. Gray1
1University of Western Australia, Department of General Surgery, Royal Perth Hospital and Cancer Research Institute, Perth, Western Australia, Australia.

Tóm tắt

Background: Despite the widespread use of surgical resection as a treatment for hepatic colorectal metastases, the value of resecting more than three metastases remains controversial. It was the objective of this study to determine if resection of larger numbers of metastases affects patient survival. Method: The survival of 123 consecutive patients who underwent curative hepatic resection for colorectal metastases between 1989 and 1999 by a single surgeon was analysed retrospectively. Kaplan–Meier survival statistics and Cox regression were used to determine the factors that affected survival, and logistic regression was used to determine the factors that affected the risk of recurrence of hepatic disease. Results: The median survival rate for the whole group of patients was 38 months, with 1, 3 and 5 year survival rates of 88%, 53% and 31% respectively. The survival rate of patients undergoing resection of four to seven metastases (n = 22; 5 year survival = 39%) was not significantly different to that of patients undergoing resection of one to three metastases (n = 91; 5 year survival = 30%), P = 0.9. Age, sex, primary cancer site, hepatic disease distribution, resection margins and adjuvant hepatic arterial chemotherapy (HAC) did not affect survival. Local invasion of the hepatic metastases (relative risk (RR) = 2.9; P = 0.001) and hepatic disease recurrence (RR = 2.1; P = 0.007) were the only factors that independently affected survival. Local invasion of the hepatic metastasis was the only factor associated with an increased risk of hepatic recurrence (RR = 2.8; P = 0.03). Adjuvant HAC did not affect the risk of hepatic recurrence (RR = 1.5, P = 0.4). Conclusion: Although there are no randomized trials that quantify any survival benefit from resection of liver metastases, the comparison of our results with well documented historical evidence indicates that surgical resection of up to seven colorectal liver metastases can result in a significant survival benefit.

Từ khóa


Tài liệu tham khảo

10.1097/00000658-198405000-00002

10.1097/00000658-199909000-00004

10.1016/S1072-7515(99)00089-7

10.1007/BF00316981

10.1046/j.1365-2168.1997.02813.x

10.1007/s002689900381

10.1007/BF02234142

10.1046/j.1365-2168.1997.02743.x

10.1046/j.1365-2168.1999.01030.x

Seifert JK, 2000, Prognostic factors following liver resection for hepatic metastases from colorectal cancer., Hepatogastroenterology, 47, 239

10.1016/S0002-9610(97)00020-2

10.1046/j.1365-2168.1997.02749.x

10.1001/archsurg.1996.01430150100019

10.1007/s002689900404

10.1007/s002689900300

10.1097/00000658-199804000-00019

10.1016/S1072-7515(97)00103-8

10.1200/JCO.1997.15.3.938

10.1016/S0002-9610(99)00070-7

ShumateCR.Hepatic resection for colorectal cancer metastases. In: Curley SA (ed.)Liver Cancer.New York: Springer Verlag 1998; 136–49.

ScheeleJ Altendorf‐HofmannA StanglRet al.Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.Br. J. Surg.1990;77: 1241.

ScheeleJ StanglR Altendorf‐HofmannA GallFP.Indicators of prognosis after hepatic resection for colorectal secondaries.Surgery1991;110: 13.

10.1002/(sici)1097-0142(19960401)77:7<1254::aid-cncr5>3.3.co;2-r

NordlingerB JaeckD GuiguetMet al.Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In: Nordlinger B Jaeck D (eds)Treatment of hepatic metastases of colorectal cancer.Paris: Springer Verlag France 1992; 129–46.

KemenyN HuangY CohenAMet al.Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.N. Engl. J. Med.1999;341: 2039–48.

10.1097/00000658-199812000-00006

Ensminger WD, 1978, A clinical pharmacological evaluation of hepatic arterial infusions of 5‐fluoro‐ 2‐deoxyuridine and 5‐fluorouracil., Cancer Res., 38, 3789

10.1046/j.1365-2168.1999.01013.x

Thông tin
Thông tin xuất bản

ANZ Journal of Surgery

Tập 72 Số 1

5-10

Thông tin tác giả